Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01724216 · ClinicalTrials.gov registry record · NA
Magnetic Resonance Imaging Using Innovative Pulse Sequences
A NA study, sponsored by GE Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT01724216 is a NA study that has completed, run by GE Healthcare. The registered enrollment target is 11 participants.
The verdict
NCT01724216, a NA study, has completed, sponsored by GE Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of the study is to collect in vivo human image data to demonstrate neurological magnetic resonance imaging (MRI) of subjects using short pulse sequences.
Interventions
- DEVICE pulse sequences
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2012-10 |
| Est. Completion | 2013-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01724216
The ClinicalTrials.gov registry entry for NCT01724216 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GE Healthcare, which has 99 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which pulse sequences is the first listed.
NCT01724216 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01724216 about?
NCT01724216 is a clinical study titled "Magnetic Resonance Imaging Using Innovative Pulse Sequences". The purpose of the study is to collect in vivo human image data to demonstrate neurological magnetic resonance imaging (MRI) of subjects using short pulse sequences.
What is the current status of trial NCT01724216?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2012-10. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01724216?
The interventions under investigation include: pulse sequences (DEVICE).
Who is sponsoring clinical trial NCT01724216?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.